Belotecan

Generic Name: Belotecan

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₇N_₃O_₄

CAS Number: 256411-32-2

Unique Ingredient Identifier: 27Z82M2G1N

Background: Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Phase 2

Completed

Conditions: Epithelial Ovarian Cancer

Interventions: Drug: Topotecan
Drug: Belotecan

First Posted Date: 2012-06-28

Last Posted Date: 2016-09-22

Lead Sponsor: Chong Kun Dang Pharmaceutical

Target Recruit Count: 141

Registration Number: NCT01630018

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Seoul Metropolitan, Korea, Republic of

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Phase 2

Completed

Conditions: Small Cell Lung Cancer

Interventions: Drug: Topotecan
Drug: Belotecan

First Posted Date: 2011-12-23

Last Posted Date: 2018-12-27

Lead Sponsor: Chong Kun Dang Pharmaceutical

Target Recruit Count: 164

Registration Number: NCT01497873

Locations: 🇰🇷
National Cancer Center, Goyang, Korea, Republic of
🇰🇷
Chungbuk University Hospital, Daegu, Korea, Republic of
🇰🇷
Keimyung University Dongsan Center, Daegu, Korea, Republic of

and more 11 locations

Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

Phase 2

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Belotecan

First Posted Date: 2009-12-01

Last Posted Date: 2016-01-28

Lead Sponsor: Chong Kun Dang Pharmaceutical

Target Recruit Count: 52

Registration Number: NCT01022671

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Phase 3

Completed

Conditions: Carcinoma, Small Cell

Interventions: Drug: Belotecan
Drug: Etoposide
Drug: Cisplatin

First Posted Date: 2009-01-22

Last Posted Date: 2021-08-09

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 147

Registration Number: NCT00826644

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy